Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD.

Thorax · 2016 · PMC4752631 · PMID 26585525

Europe PMC DOI

hedged sentences

0.1860

closest p · 3.7× alpha

0.1860

boldest claim

The sentences

did not reach statistical significancep=0.186not close (p > 0.1)

In the <2% eosinophils subgroup, the rate of these exacerbations was 18% higher in patients receiving FP/SAL than in those who received tiotropium, although these treatment differences did not reach statistical significance (p=0.186).

also in 111,027 other papers

did not achieve significanceno p-value reported

Comparisons of FP/SAL versus FP or SAL did not achieve significance in either subgroup.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.